Avara Pharmaceutical Services - About the company
Avara Pharmaceutical Services is a funded company based in Norwalk (United States), founded in 1995. It operates as a Pharmaceutical contract manufacturing organization providing sterile fill-finish, OSD drug product, and integrated packaging. The company has 369 active competitors, including 16 funded and 91 that have exited. Its top competitors include companies like Aizant, Almac Group and Concord Biotech.
Company Details
Pharmaceutical contract manufacturing organization providing sterile fill-finish, OSD drug product, and integrated packaging. The company is committed to collaborative relationships, producing quality pharmaceutical products. They offer expertise in process development, including liquid and lyophilized steriles, oral solid dosage forms, and potent compounds, supported by analytical services. Integrated packaging solutions are provided for manufactured dosage forms, including primary and secondary packaging, automated inspection, and serialization. The company focuses on attentiveness, flexibility, and client success in drug product manufacturing. They offer clinical and commercial-scale manufacturing of oral solid dose drug products, including potent compounds and targeted release formulations. Their sterile fill-finish capabilities include liquid and lyophilized fill-finish of sterile injectable products, with terminal sterilization and high containment for potent compounds.
- Website
- www.avara.com/
- Email ID
- *****@avara.com
- Registered Address
- Norman, Oklahoma
Key Metrics
Founded Year
1995
Location
Norwalk, United States
Stage
Funding Raised
Investors
Ranked
98th among 369 active competitors
Legal entities associated with Avara Pharmaceutical Services
Avara Pharmaceutical Services is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
AVARA PHARMACEUTICAL SERVICES, INC. CIN: 473599330 , United States, Active | Dec 26, 999 | - | 310 (As on Dec 31, 2024) | - |
AVARA INTERNATIONAL LTD CIN: 10064464 , United Kingdom, Active | Mar 14, 2016 | - | - | |
AVARA HOLDINGS LTD CIN: 10064498 , United Kingdom, Active | Mar 14, 2016 | - | 1 (As on Dec 31, 2022) |
Sign up to download Avara Pharmaceutical Services' company profile
Avara Pharmaceutical Services's funding and investors
Avara Pharmaceutical Services is a funded company. Avara Pharmaceutical Services has 1 institutional investor.
View details of Avara Pharmaceutical Services's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Avara Pharmaceutical Services's Competitors and alternates
Top competitors of Avara Pharmaceutical Services include Aizant, Almac Group and Concord Biotech. Here is the list of Top 10 competitors of Avara Pharmaceutical Services, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Company offering contract development services for small molecules | $16.8M | 60/100 | ||
2nd | Almac Group 2001, Craigavon (United Kingdom), Series D | CRAMS company offering preclinical development and CDMO services, also offering companion diagnostic development | $339M | 57/100 | |
3rd | Concord Biotech 2000, Ahmedabad (India), Public | CDMO focused on manufacturing API | - | 56/100 | |
4th | Nucleus RadioPharma 2022, Rochester (United States), Series A | CDMO focused on providing of radiopharmaceuticals manufacturing and supply chain services | $72.1M | 55/100 | |
5th | Indoco Remedies 1947, Mumbai (India), Public | Provider of APIs manufacturing and formulation services | - | 54/100 | |
6th | CDMO focused on amino acids and small molecules | - | - | 53/100 | |
7th | Development and manufacturing of niche pharmaceutical products for the generic industry | $2.74M | 52/100 | ||
8th | Sabinsa 1988, East Windsor (United States), Unfunded | Manufacturing and marketing nutraceuticals, cosmeceuticals and fine chemicals | - | - | 52/100 |
9th | Turnkey solutions for drug development, manufacturing and regulatory approvals | - | 52/100 | ||
10th | Wanbury Limited 1990, Mumbai (India), Public | Manufacturer of anti-diabetic drugs | - | - | 51/100 |
98th | Avara Pharmaceutical Services 1995, Norwalk (United States), Funding Raised | Pharmaceutical contract manufacturing organization providing sterile fill-finish, OSD drug product, and integrated packaging | - | 32/100 |
Looking for more details on Avara Pharmaceutical Services's competitors? Click here to see the top ones
Avara Pharmaceutical Services's Investments and acquisitions
Avara Pharmaceutical Services has made no investments or acquisitions yet.
News related to Avara Pharmaceutical Services
Media has covered Avara Pharmaceutical Services for a total of 2 events in the last 1 year, 1 of them has been about company updates.
•
IDA Wins Legal Battle Over Repayment of €1.19 Million Grant to Bankrupt Pharma Company Avaralesactualites.news•Nov 18, 2025•IDA Ireland, Avara Pharmaceutical Services
•
•
•
Lens by Avara secures $31M for SocialFi-focused L2 blockchainCryptocurrency•Dec 19, 2024•Avara Pharmaceutical Services, SocialFi
•
Avara Highlights Recent Expansions and Core CapabilitiesContract Pharma•Sep 17, 2024•Avara Pharmaceutical Services
•
•
•
•
•
Avara’s Acquisition of Commercial Property in TapiolaGlobal Legal Chronicle•Sep 20, 2022•Avara Pharmaceutical Services, Nordea, Merilampi
Are you a Founder ?
FAQs about Avara Pharmaceutical Services
Explore our recently published companies
- York Tower - New York based, 2010 founded, Unfunded company
- Grasmueck - Germany based, Unfunded company
- Bratanovic - Umag based, Unfunded company
- Guidepost-Strategy - Unfunded company
- Byronconsulting - Unfunded company
- Emanation - 2015 founded, Unfunded company